Skip to main content
Premium Trial:

Request an Annual Quote

Vanderbilt Lands $10M for Proteomics Imaging

By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – Vanderbilt University has won a five-year, $10.3 million grant award from the National Center for Research Resources to establish an NCRR resource focused on imaging mass spectrometry, Vanderbilt said late last week.

The National Research Resource for Imaging Mass Spectrometry will support the development of next-generation hardware, software, and methods for direct tissue profiling and imaging using mass specs.

The research areas supported by these new imaging technologies include high spatial resolution imaging of serotonin neurons in neurodevelopmental disorders, studies of cervical and brain cancers, age-related macular degeneration, and tumor blood vessel development, among others, the university said.

The imaging resource also will provide short training courses and scientific visits to encourage collaborations.

“Imaging mass spectrometry gives the research scientist and the physician a new and unprecedented view of the molecular changes underlying disease processes,” explained Richard Caprioli, director of Vanderbilt's Mass Spectrometry Research Center and leader of the new program, in a statement.

According to Vanderbilt, Caprioli expects that the resource will be an agent for moving imaging mass spectrometry from instrumental developmental labs to biological and clinical research labs as a routine imaging tool.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.